What is Extendicare's stock price target for 2024?

0 Wall Street analysts have issued 12 month price targets for Extendicare's stock. Their EXETF share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 31.8% from the stock's current price. View analysts price targets for EXETF or view top-rated stocks among Wall Street analysts .

How have EXETF shares performed in 2024?

Extendicare's stock was trading at $5.4940 at the beginning of the year. Since then, EXETF stock has decreased by 3.3% and is now trading at $5.31. View the best growth stocks for 2024 here .

Are investors shorting Extendicare?

Extendicare saw a increase in short interest in March. As of March 31st, there was short interest totaling 592,200 shares, an increase of 22.7% from the March 15th total of 482,800 shares. Based on an average daily trading volume, of 3,500 shares, the days-to-cover ratio is currently 169.2 days. View Extendicare's Short Interest .

When is Extendicare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our EXETF earnings forecast .

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare declared a dividend on Thursday, March 21st. Investors of record on Thursday, March 28th will be paid a dividend of $0.0297 per share on Monday, April 15th. This represents a yield of 6.35%. The ex-dividend date of this dividend is Wednesday, March 27th. This is an increase from the stock's previous dividend of $0.03. Read our dividend analysis for EXETF .

Is Extendicare a good dividend stock?

Extendicare (OTCMKTS:EXETF) pays an annual dividend of $0.48 per share and currently has a dividend yield of 8.00%. EXETF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for EXETF .

How do I buy shares of Extendicare?

Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:EXETF

Extendicare (EXETF) Stock Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)

Free EXETF Stock Alerts

$5.31

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $5.28
▼
$5.31
50-Day Range: $4.74
▼
$5.83
52-Week Range: $4.10
▼
$5.83

Volume: 72 shs
Average Volume: 5,489 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 9.04%
Price Target: $7.00

Stock Analysis Analyst Forecasts Chart Dividend Headlines Short Interest

Get Extendicare alerts:

Extendicare MarketRank™ Stock Analysis

Analyst Rating: 0.00 Rating Score
Upside/Downside: 31.8% Upside
$7.00 Price Target
Short Interest: Bearish
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.08 out of 5 stars

2.0

Analyst's Opinion

Amount of Analyst Coverage
Extendicare has received no research coverage in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
Short Interest Ratio / Days to Cover
Extendicare has a short interest ratio ("days to cover") of 169.2, which indicates bearish sentiment.
Change versus previous month
Short interest in Extendicare has recently increased by 22.66%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Leadership
Extendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Extendicare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EXETF.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Extendicare this week, compared to 0 articles on an average week.
Search Interest
1 people have searched for EXETF on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Extendicare insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 9.44% of the stock of Extendicare is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Extendicare is -20.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Extendicare is -20.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

The Next Nvidia?

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.

About Extendicare Stock (OTCMKTS:EXETF)

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

EXETF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EXETF Stock News Headlines

April 15, 2024 | globenewswire.com

Extendicare Announces April 2024 Dividend of C$0.04 per Share

March 27, 2024 | finance.yahoo.com

Ontario Nurses' Association Pickets at Extendicare Canada to Launch Nursing Homes Bargaining Campaign Calling for Care, Not Profit

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 15, 2024 | msn.com

Kingston looks at primary health clinic option for former Extendicare facility

March 7, 2024 | globenewswire.com

Extendicare Announces 2023 Fourth Quarter and Year End Results

February 29, 2024 | wsj.com

Extendicare Inc.

February 15, 2024 | prnewswire.com

Extendicare Opens the Market

February 15, 2024 | globenewswire.com

Extendicare Announces February 2024 Dividend of C$0.04 per Share

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 5, 2024 | msn.com

Neighbours oppose plans for supportive housing at Kingston Extendicare facility

February 2, 2024 | msn.com

City of Kingston buys Extendicare facility, supportive housing planned

January 22, 2024 | msn.com

Extendicare Kirkland Lake declares suspected enteric outbreak

January 10, 2024 | msn.com

Extendicare Kirkland Lake declares COVID-19 outbreak

November 13, 2023 | seekingalpha.com

Extendicare Inc. (EXETF) Q3 2023 Earnings Call Transcript

November 10, 2023 | finanznachrichten.de

Extendicare Inc: Extendicare Announces 2023 Third Quarter Results

November 8, 2023 | finance.yahoo.com

Those who invested in Extendicare (TSE:EXE) five years ago are up 19%

October 6, 2023 | markets.businessinsider.com

Extendicare Announces Timing of 2023 Third Quarter Results and Conference Call

September 13, 2023 | finance.yahoo.com

Should You Investigate Extendicare Inc. (TSE:EXE) At CA$6.16?

August 17, 2023 | markets.businessinsider.com

RBC Capital Keeps Their Hold Rating on Extendicare (EXE)

August 11, 2023 | msn.com

Workers at Extendicare Kingston on information picket line over payroll issues

August 11, 2023 | finanznachrichten.de

Extendicare Inc: Extendicare Announces 2023 Second Quarter Results

August 11, 2023 | markets.businessinsider.com

Extendicare Announces 2023 Second Quarter Results

July 16, 2023 | theglobeandmail.com

Extendicare: Stocks Overvalued by Analyst Consensus on TSX (EXE)

July 6, 2023 | benzinga.com

Extendicare Announces Timing of 2023 Second Quarter Results and Conference Call

June 15, 2023 | finance.yahoo.com

Extendicare Announces June 2023 Dividend of C$0.04 per Share

June 12, 2023 | theglobeandmail.com

Closing Bell: Extendicare Inc 5 Pct Debs down on Monday (EXE-DB-C)

May 29, 2023 | finance.yahoo.com

Extendicare Announces Voting Results for its 2023 Annual Meeting of Shareholders

See More Headlines

Receive EXETF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend: 2/28/2024
Dividend Payable: 3/15/2024
Ex-Dividend for 4/15 Dividend: 3/27/2024
Dividend Payable: 4/15/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/15/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Care Facilities
Sub-Industry: N/A
Current Symbol: OTCMKTS:EXETF
CUSIP: N/A
CIK: N/A
Web: www.extendicare.com
Phone: (905) 470-4000
Fax: N/A
Employees: 23,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.00
High Stock Price Target: $7.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +32.7%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Michael R. Guerriere M.D. (Age 60)
MBA, CEO, President & Director
Comp: $818.93k
Mr. David E. Bacon
Senior VP & CFO
Mr. John Toffoletto
Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Matthew Morgan
Chief Medical Officer
Mr. Steve Paraskevopoulos
Senior Vice President of ParaMed & CTO
Joe Belinsky
VP of Information Technology & Chief Information Officer
Ms. Jillian E. Fountain
Vice President of Investor Relations
Ms. Kathryn Killoran Bradley
Vice President of Corporate Development
Ms. Katie LeMoyne
Senior VP & Chief HR Officer
Ms. Wendy Gilmour
Senior VP of LTC Operations

Key Competitors

View All Competitors

EXETF Stock Analysis - Frequently Asked Questions

What is Extendicare's stock price target for 2024?: 0 Wall Street analysts have issued 12 month price targets for Extendicare's stock. Their EXETF share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 31.8% from the stock's current price.
View analysts price targets for EXETF or view top-rated stocks among Wall Street analysts.
How have EXETF shares performed in 2024?: Extendicare's stock was trading at $5.4940 at the beginning of the year. Since then, EXETF stock has decreased by 3.3% and is now trading at $5.31.
View the best growth stocks for 2024 here.
Are investors shorting Extendicare?: Extendicare saw a increase in short interest in March. As of March 31st, there was short interest totaling 592,200 shares, an increase of 22.7% from the March 15th total of 482,800 shares. Based on an average daily trading volume, of 3,500 shares, the days-to-cover ratio is currently 169.2 days.
View Extendicare's Short Interest.
When is Extendicare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024.
View our EXETF earnings forecast.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?: Extendicare declared a dividend on Thursday, March 21st. Investors of record on Thursday, March 28th will be paid a dividend of $0.0297 per share on Monday, April 15th. This represents a yield of 6.35%. The ex-dividend date of this dividend is Wednesday, March 27th. This is an increase from the stock's previous dividend of $0.03.
Read our dividend analysis for EXETF.
Is Extendicare a good dividend stock?: Extendicare (OTCMKTS:EXETF) pays an annual dividend of $0.48 per share and currently has a dividend yield of 8.00%. EXETF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for EXETF.
How do I buy shares of Extendicare?: Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EXETF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Extendicare (EXETF) Stock Price, News & Analysis

Extendicare MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Amount of Analyst Coverage

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Dividend Leadership

Dividend Growth